Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma-Reference-Cited by-同舟云学术

Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma

Published:2020-11-24 Issue:2 Volume:12 Page:235-244
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Choi Sun Ha¹²,Jeong Ji Yun³,Lee Shin Yup¹²⁴^ORCID,Shin Kyung Min⁵^ORCID,Jeong Shin Young⁶,Park Tae‐In³,Do Young Woo²⁷,Lee Eung Bae²⁷,Seok Yangki²⁸,Lee Won Kee⁹,Park Ji Eun¹,Park Sunji¹,Lee Yong Hoon¹,Seo Hyewon¹,Yoo Seung Soo¹²,Lee Jaehee¹,Cha Seung‐Ick¹,Kim Chang Ho¹,Park Jae Yong¹²^ORCID

Affiliation:

1. Department of Internal Medicine, School of Medicine Kyungpook National University Daegu Korea

2. Lung Cancer Center Kyungpook National University Chilgok Hospital Daegu Korea

3. Department of Pathology, School of Medicine Kyungpook National University Daegu Korea

4. Vessel‐Organ Interaction Research Center Kyungpook National University Daegu Korea

5. Department of Radiology, School of Medicine Kyungpook National University Daegu Korea

6. Department of Nuclear Medicine, School of Medicine Kyungpook National University Daegu Korea

7. Department of Thoracic Surgery, School of Medicine Kyungpook National University Daegu Korea

8. Department of Thoracic Surgery Soonchunhyang University Gumi Hospital Gumi Korea

9. Medical Research Collaboration Center in Kyungpook National University Hospital and School of Medicine Kyungpook National University Daegu Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13754

Reference23 articles.

1. Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer

2. Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

3. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

4. National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology Non‐Small Cell Lung Cancer Version 3.2020.https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf

5. The 2015 World Health Organization Classification of Lung Tumors

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes;World Journal of Surgical Oncology;2024-09-05

2. CT morphological features and histogram parameters to predict micropapillary or solid components in stage IA lung adenocarcinoma;Frontiers in Oncology;2024-07-24

3. Genetic profile characterization of histological micropapillary and solid components in lung adenocarcinoma: a systematic review;Journal of Laboratory and Precision Medicine;2024-07

4. The International Association for the Study of Lung Cancer (IASLC) Staging Project for Lung Cancer: Recommendation to Introduce Spread Through Air Spaces as a Histologic Descriptor in the Ninth Edition of the TNM Classification of Lung Cancer. Analysis of 4061 Pathologic Stage I NSCLC;Journal of Thoracic Oncology;2024-07

5. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma;BMC Cancer;2024-06-05